Clark Estates »

Indivior Pharmaceuticals shares owned by Clark Estates

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by Clark Estates from 13F filings

Historical chart of Clark Estates investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by Clark Estates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by Clark Estates

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.8M 92k 30.48

More positions owned by Clark Estates

Ea Series Trust Euclidean Fundam (ECML)
Walt Disney Company (DIS)
Solventum Corp Com Shs (SOLV)
Unilever Spon Adr New (UL)
Warner Music Group Corp Com Cl A (WMG)
Iqvia Holdings (IQV)
Amrize SHS (AMRZ)
Sony Group Corp Sponsored Adr (SONY)
Haleon Spon Ads (HLN)
Medtronic SHS (MDT)
Bausch Plus Lomb Corp Common Shares (BLCO)
Halyard Health (AVNS)
Shattuck Labs (STTK)
Smith & Nephew Spdn Adr New (SNN)
Gilead Sciences (GILD)

View all positions for Clark Estates

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Madison Avenue Partners
Vanguard Capital Management
Two Seas Capital
Millennium Management
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Goldman Sachs Group
UBS Group
Driehaus Capital Management
Newtyn Management

View all funds holding Indivior Pharmaceuticals